Realcan Pharmaceutical Group

Launch date

Sep 2004

Employees

Market cap

Enterprise valuation

€674m (Public information from Sep 2024)

Fushan District Shandong (HQ)

http://realcan.cn

https://www.linkedin.com/company/shandong-realcan-pharmaceutical-co-ltd-

Revenues, earnings & profits over time

CNY	2017	2018	2019	2020	2021	2022	2023
Revenues	-	-	35.3b	27.2b	21.1b	12.3b	8.0b
% growth	-	-	-	(23 %)	(23 %)	(42 %)	(35 %)
EBITDA	-	-	2.8b	2.0b	1.6b	(543m)	449m
% EBITDA margin	-	-	8 %	7 %	8 %	(4 %)	6 %
Profit	-	-	(928m)	261m	131m	(1.8b)	20.3m
% profit margin	-	-	(3 %)	1 %	1 %	(15 %)	-
EV / revenue	-	-	0.4x	0.5x	0.3x	0.4x	0.8x
EV / EBITDA	-	-	4.6x	6.1x	3.6x	-8.9x	15.1x
R&D budget	-	-	7.0m	8.9m	11.6m	22.7m	14.6m

Date	Investors	Amount	Round
Jun 2011	N/A	N/A	IPO
Total Funding		-

Zheshang Venture Capital